<qa>  What is the primary objective for Phase III?For Phase III stage the primary objective is to compare progression-free survival PFS on the three arms. Secondary objectives are to determine treatment related toxicity; to determine tumour response rates RECIST criteria; to determine overall survival for each treatment arm; to compare disease related symptoms and Quality of life and to determine cost effectiveness of bevacizumab containing treatments. 